OTC & PINK Stocks to Watch (Attitude Drinks, Advanced Cell Technology, Growlife Inc, Entest BioMedical Inc)

Houston, TX -- (SBWIRE) -- 02/11/2013 -- AnotherWinningTrade.com offers its daily alerts and market content newsletter to investors looking for the best information available! AnotherWinningTrade.com provides its subscribers with useful, timely information and exclusive alerts on penny stocks, mid cap stocks and large cap stocks with the potential to deliver gains of 100%-200% or more. We have the top alerts in the industry. To receive our FREE, comprehensive newsletter, visit AnotherWinningTrade.com.

Attitude Drinks Inc (NDA) (OTC:ATTD) is higher 50.00% and is trading at $0.0003. Attitude Drinks Incorporated (Attitude) is a development-stage company. The Company focuses on the non-alcoholic single serving beverage business, developing and marketing of milk based products in two segments: sports recovery and functional dairy.

Can ATTD Rebound After The Recent Slump and Investors Can Make Money? Find Out Here

Advanced Cell Technology, Inc. (OTC:ACTC) is higher 3.07% and is trading at $0.0807. Advanced Cell Technology, Inc. is a biotechnology company focused on developing and commercializing human embryonic and adult stem cell technology in the emerging field of regenerative medicine. The Company has acquired, developed and maintained a portfolio of patents and patent applications that forms the base for its research and development efforts in the area of embryonic and adult stem cell research.

How Should Investors Trade ACTC After The Recent Volatile Moves? Find Out Here

Growlife Inc (OTC:PHOT) fell 7.79% and is trading at $0.0710. GrowLife, Inc., formerly, Phototron Holdings, Inc. sells and distributse mini-hydroponic greenhouses (Phototron Units) and horticultural seeds, mineral nutrient solutions, growing mediums and germination kits.

Is PHOT Showing Any Sign of Buy At The Current Market Price? Get Our Free Trend Analysis Here

Entest BioMedical Inc. (PINK:ENTB) is higher 48.00% and is trading at $0.0037. Entest BioMedical, Inc. (Entest) is a development-stage company. The Company focuses on development and commercialization of immunotherapeutic therapies for the veterinary market, as well as the acquisition and operation of veterinary hospitals.

Can ENTB Rebound After The Recent Slump and Investors Can Make Money? Find Out Here

Disclaimer
Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid IO News Wire twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation; do no trading of any kind and send no faxes or emails.

Contact Information
Winning Media LLC
1-800-411-7716
ir@AnotherWinningTrade.com